Trust, democracy and COVID-19: A British perspective
In this Democracy 2025 podcast, Mark Evans and Michelle Grattan explore differences in the management, experience and impact of the COVID-19 crisis between Australia and the UK.
If you’re lucky enough to be able to afford a ski trip, expect it to look different this year. Some extra planning, however, can lower the coronavirus risk to you, your loved ones and the community.
Canada could emerge from this pandemic with a better quality, expanded and more efficient child-care system nationwide while making an investment with returns in the future.
Pandemic devastation surrounds it on all sides, but tiny Uruguay has COVID-19 under control – just the latest win for a country that’s always stood out.
It usually takes 10 years for a new vaccine to complete clinical trials, but we’ve been promised a COVID-19 vaccine in 12 to 18 months. Even if such fast-tracked development is possible, is it wise?
The COVID-19 pandemic is an opportunity to think critically about the place of prisons in society and how and why prisoners have been released in the past. COVID-19 could spark systemic change.
African policymakers should strenuously safeguard their right to choose from the widest possible range of technology options that suit their countries’ development needs.
Goddesses have traditionally protected against sickness and cured the ill, according to Hindu belief. More recently they have been coopted to combat AIDS and traffic deaths.
People have lived with infectious disease throughout the millennia, with culture and biology influencing each other. Archaeologists decode the stories told by bones and what accompanies them.
In this week’s round-up of coronavirus articles by scholars around the globe, we explore the disproportionate impacts of COVID-19 and the latest on drug trials.
A Mitchell Institute report has estimated the proportion of international students in various Australian suburbs, and how much they contribute to the local economy.
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand